Optimal therapy schedule of chimeric antigen receptor (CAR) T cell immunotherapy
Mathematical Biosciences and Engineering · 2025
DOI: 10.3934/mbe.2025061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mathematical Biosciences and Engineering, 2025. Verfasst von Ruohan Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Mathematical Sciences, Tiangong University, Tianjin 300387, China. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Immunotherapy, Adoptive, T-Lymphocytes, Neoplasms. Die Arbeit nennt 48 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Mathematical Sciences, Tiangong University, Tianjin 300387, China.
- Center for Applied Mathematics, Tiangong University, Tianjin 300387, China.
Zitieren
APA
Li, R., & Lei, J. (2025). Optimal therapy schedule of chimeric antigen receptor (CAR) T cell immunotherapy. Mathematical Biosciences and Engineering. https://doi.org/10.3934/mbe.2025061
Vancouver
Li R, Lei J. Optimal therapy schedule of chimeric antigen receptor (CAR) T cell immunotherapy. Mathematical Biosciences and Engineering. 2025. doi:10.3934/mbe.2025061
BibTeX
@article{Li2025,
author = {Li, Ruohan and Lei, Jinzhi},
title = {Optimal therapy schedule of chimeric antigen receptor (CAR) T cell immunotherapy},
journal = {Mathematical Biosciences and Engineering},
year = {2025},
doi = {10.3934/mbe.2025061}
}
EUVIMED